The second Trump administration has implemented severe funding rollbacks affecting vital medical research, particularly cancer studies. A suspension of communications at the Department of Health and Human Services has led to mass cancellations of NIH meetings and grant proposals, stalling crucial funding processes. Researchers like Chrystal Starbird and Emily Gillespie have reported the abrupt stoppage of their planned involvement in grant reviews and funding new projects. This disruption poses a significant threat to groundbreaking medical programs and ongoing trials, leaving many researchers uncertain about future funding and progress in their fields.
"I've never seen a complete pause like this as part of a transition," the researcher told Mother Jones.
With that one-two punch, the state of funding for any new trials - and for billions of dollars worth of other important programs, including foreign aid - remains on hold, its future uncertain.
Collection
[
|
...
]